Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A clearer view on ovarian clear cell carcinoma.
De Pauw A, Naert E, Van de Vijver K, Philippe T, Vandecasteele K, Denys H. De Pauw A, et al. Among authors: van de vijver k. Acta Clin Belg. 2022 Aug;77(4):792-804. doi: 10.1080/17843286.2021.1964051. Epub 2021 Aug 17. Acta Clin Belg. 2022. PMID: 34404331
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment.
Lippens L, Van Bockstal M, De Jaeghere EA, Tummers P, Makar A, De Geyter S, Van de Vijver K, Hendrix A, Vandecasteele K, Denys H. Lippens L, et al. Among authors: de geyter s, van bockstal m, de jaeghere ea, van de vijver k. Int J Cancer. 2020 Jul 15;147(2):554-564. doi: 10.1002/ijc.32893. Epub 2020 Feb 26. Int J Cancer. 2020. PMID: 32017078 Free article.
Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma.
De Thaye E, Van de Vijver K, Van der Meulen J, Taminau J, Wagemans G, Denys H, Van Dorpe J, Berx G, Ceelen W, Van Bocxlaer J, De Wever O. De Thaye E, et al. Among authors: van der meulen j, van dorpe j, de wever o, van bocxlaer j, van de vijver k. Sci Rep. 2020 Apr 21;10(1):6688. doi: 10.1038/s41598-020-63738-6. Sci Rep. 2020. PMID: 32317693 Free PMC article.
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
De Jaeghere EA, Laloo F, Lippens L, Van Bockstal M, De Man K, Naert E, Van Dorpe J, Van de Vijver K, Tummers P, Makar A, De Visschere PJL, De Wever O, Amant F, Denys HG, Vandecasteele K. De Jaeghere EA, et al. Among authors: de man k, van dorpe j, de wever o, van bockstal m, de visschere pjl, van de vijver k. Gynecol Oncol. 2020 Nov;159(2):335-343. doi: 10.1016/j.ygyno.2020.08.001. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32859399
Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.
Van Hulle H, Vakaet V, Post G, Van Greveling A, Monten C, Hendrix A, Van de Vijver K, Van Dorpe J, De Visschere P, Braems G, Vandecasteele K, Denys H, De Neve W, Veldeman L. Van Hulle H, et al. Among authors: van dorpe j, de neve w, de visschere p, van de vijver k, van greveling a. Pilot Feasibility Stud. 2020 Oct 10;6:154. doi: 10.1186/s40814-020-00693-z. eCollection 2020. Pilot Feasibility Stud. 2020. PMID: 33062295 Free PMC article.
Treatment algorithm in patients with ovarian cancer.
Vergote I, Denys H, De Greve J, Gennigens C, Van De Vijver K, Kerger J, Vuylsteke P, Baurain JF. Vergote I, et al. Among authors: de greve j, van de vijver k. Facts Views Vis Obgyn. 2020 Oct 8;12(3):227-239. Facts Views Vis Obgyn. 2020. PMID: 33123697 Free PMC article.
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, Mirza MR, Brasiuniene B, Madry R, Brenton JD, Ausems MGEM, Büttner R, Lambrechts D; European experts’ consensus group. Vergote I, et al. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. Epub 2021 Dec 1. Ann Oncol. 2022. PMID: 34861371 Free article. Review.
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian Cancer.
Loret N, Vandamme N, De Coninck J, Taminau J, De Clercq K, Blancke G, Jonckheere S, Goossens S, Lemeire K, De Prijck S, Verstaen K, Seurinck R, Van Dorpe J, Weyers S, Denys H, Van de Vijver K, Lambrecht BN, Tummers P, Saeys Y, Berx G. Loret N, et al. Among authors: de prijck s, van dorpe j, de coninck j, van de vijver k, de clercq k. Mol Cancer Res. 2022 Oct 4;20(10):1532-1547. doi: 10.1158/1541-7786.MCR-21-0565. Mol Cancer Res. 2022. PMID: 35749080
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nuffel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: van dam pa, van nuffel amt, de caluwe a, de wever o, van de vijver kk. Cancer Immunol Immunother. 2023 Feb;72(2):475-491. doi: 10.1007/s00262-022-03253-x. Epub 2022 Aug 12. Cancer Immunol Immunother. 2023. PMID: 35960332 Free PMC article. Clinical Trial.
195 results